Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373425
Status:
COMPLETED
Last Update Posted:
2015-09-17
First Post:
2006-09-07
Brief Title:
A Study of Erlotinib Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma NSCLC Patients Who Have Epidermal Growth Factor Receptor EGFR Positive Tumors
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Organization Data
Organization:
Astellas Pharma Inc
Class:
INDUSTRY
Study ID:
OSI-774-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OSI Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None